Revenio Group Oyj

Governance Information • Aug 4, 2014

Disclosure 316840

Revenio Group Oyj - Company Announcement

Revenio Group Corporation: REVENIO'S BOARD OF DIRECTORS CONFIRMS THE COMPANY'S DISCLOSURE POLICY

Revenio Group Corporation Stock Exchange Release 4 August 2014 at 9:05 hrs REVENIO'S BOARD OF DIRECTORS CONFIRMS THE COMPANY'S DISCLOSURE POLICY Revenio Group Corporation's Board of Directors has confirmed Revenio's disclosure policy whose key objective is to ensure that all operators in the market have an access to simultaneously sufficient and accurate information on the company and its business operations to establish the price formation of securities issued by the company. The most important change from the company's previous practice is the harmonization of the quiet period and the closed window so that both now begin 14 days prior to the publication of interim reports and 21 days prior to the publication of financial statements. The disclosure policy is available in full on the company website at http://www.reveniogroup.fi/en/investor-communications/ Revenio Group Corporation Olli-Pekka Salovaara President & CEO For additional information, please contact President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520 olli-pekka.salovaara@revenio.fi DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Principal media www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group's success. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. The Revenio Group also includes other business operations, which are grouped under the Technology and Services segment. This segment's operations have a shared global market and represent the cutting edge of technology products and services in their industry. These businesses generate positive cash flow for the Group. In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its operating margin standing at 21.7 %. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki. [HUG#1845722]